Jeffrey Scott Riley - Director at Gain Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
GANX on Nasdaq
All Insider Reports
All Insider Reports

Jeffrey Scott Riley - trading volume in the past year for Gain Therapeutics, Inc.

Holdings reported by Jeffrey Scott Riley for Gain Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 30K $116K $3.86 Mar 28, 2024 Direct
Stock Option (right to buy) 15K Jun 24, 2024 Direct Common Stock

Transactions reported by Jeffrey Scott Riley for Gain Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.